Minocycline affects microglia activation, Aβ deposition, and behavior in APP-tg mice

GLIA

Volumn 53, Issue 7, 2006, Pages 776-782

  Seabrook, Timothy J ^a,b   Jiang, Liying ^a   Maier, Marcel ^a   Lemere, Cynthia A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NRB   (United States)

Author keywords

Alzheimer's disease; Amyloid; Anti inflammatory; Cytokines; Microglia activation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MINOCYCLINE; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL ACTIVATION; COGNITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG INHIBITION; HIPPOCAMPUS; IN VITRO STUDY; MICROGLIA; MOUSE; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AGE FACTORS; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BRAIN; CELL LINE, TUMOR; CELLS, CULTURED; COGNITION; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; GLIOSIS; HUMANS; MICE; MICE, TRANSGENIC; MICROGLIA; MINOCYCLINE; SENILE PLAQUES; UP-REGULATION;

EID: 33646243562     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20338     Document Type: Article

References (31)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole G, Cooper N, Eikelenboom P, Emmerling M, Fiebich B, et al. 2000. Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421.
2. Citron M, Teplow DB, Selkoe DJ. 1995. Generation of amyloid β-protein from its precursor is sequence specific. Neuron 14:661-670.
3. Dickson DW. 1997. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56:321-339.
4. Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F. 2004. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci 19:3266-3276.
5. Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, et al. 2001. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 98:14669-14674.
6. Eriksen J, Sagi S, Smith T, Weggen S, Das P, McLendon D, Ozols V, Jessing K, Zavitz K, Koo E, et al. 2003. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest 112:440-449.
7. Familian A, Boshuizen RS, Eikelenboom P, Veerhuis R. 2006. Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation. Glia 53:233-240.
8. Farris W, Mansourian S, Leissring MA, Eckman EA, Bertram L, Eckman CB, Tanzi RE, Selkoe DJ. 2004. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol 164:1425-1434.
9. Gasparini L, Ongini E, Wenk G. 2004. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action. J Neurochem 91:521-536.
10. Gordon PH, Moore DH, Gelinas DF, Qualls C, Meister ME, Werner J, Mendoza M, Mass J, Kushner G, Miller RG. 2004. Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology 62:1845-1847.
11. Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A, Trauger JW. 2005. Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 94:819-827.
12. Lee HG, Casadesus G, Zhu X, Takeda A, Perry G, Smith MA. 2004. Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Ann NY Acad Sci 1019:1-4.
13. Li WW, Setzu A, Zhao C, Franklin RJ. 2005. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 158:58-66.
14. Metz LM, Zhang Y, Yeung M, Patry DG, Bell RB, Stoian CA, Yong VW, Patten SB, Duquette P, Antel JP, et al. 2004. Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 55:756.
15. Mucke L, Masliah E, Yu G-Q, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. 2000. High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20:4050-4058.
16. Palop JJ, Jones B, Kekonius L, Chin J, Yu GQ, Raber J, Masliah E, Mucke L. 2003. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci USA 100:9572-9577.
17. Pedraza CE, Podlesniy P, Vidal N, Arevalo JC, Lee R, Hempstead B, Ferrer I, Iglesias M, Espinet C. 2005. Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR. Am J Pathol 166:533-543.
18. Rogers J, Strohmeyer R, Kovelowski C, Li R. 2002. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40:260-269.
19. Ryu JK, Franciosi S, Sattayaprasert P, Kim SU, McLarnon JG. 2004. Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus. Glia 48:85-90.
20. Saura J, Tusell JM, Serratosa J. 2003. High-yield isolation of murine microglia by mild trypsinization. Glia 44:183-189.
21. Seabrook TJ, Bloom JK, Iglesias M, Spooner ET, Walsh DM, Lemere CA. 2004. Species-specific immune response to immunization with human versus rodent A beta peptide. Neurobiol Aging 25:1141-1151.
22. Selkoe D. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766.
23. Streit W. 2002. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133-139.
24. Sung S, Yao Y, Uryu K, Yang H, Lee VM, Trojanowski JQ, Pratico D. 2004. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. Faseb J 18:323-325.
25. Suzuki T, Hide I, Ido K, Kohsaka S, Inoue K, Nakata Y. 2004. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci 24:1-7.
26. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. 2001. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580-2588.
27. Tikka T, Koistinaho J. 2001. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166:7527-7533.
28. Walsh DM, Selkoe DJ. 2004. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 11:213-228.
29. Wilcock DM, Rojiani A, Rosenthal A, Levkowitz G, Subbarao S, Alamed J, Wilson D, Wilson N, Freeman MJ, Gordon MN, et al. 2004. Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J Neurosci 24:6144-6151.
30. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769-15774.
31. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu du C, et al. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417:74-78.